NCT05823012 - Study of XP-8121 For the Treatment of Adult Subjects With Hypothyroidism | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 15, 2023

Primary Completion Date

February 22, 2024

Study Completion Date

February 22, 2024

Conditions

Hypothyroidism

Interventions

DRUG

levothyroxine sodium

Levothyroxine sodium 10 mg/mL

Trial Locations (6)

Panax Clinical Research, LLC, Miami Lakes

Mt. Olympus Medical Research, LLC, Sugar Land

American Research Corporation, San Antonio

Catalina Research Institute, L.L.C., Montclair

ProSciento, Inc., Chula Vista

Rainier Clinical Research Center, Renton